Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults

OBJECTIVES: In Canada, incidences of herpes zoster (HZ) and postherpetic neuralgia (PHN) are increasing, posing a significant burden on the healthcare system. This study aimed to determine the public health impact and cost effectiveness of an adjuvanted recombinant zoster vaccine (RZV) compared to n...

Descripción completa

Detalles Bibliográficos
Autores principales: McGirr, Ashleigh, Van Oorschot, Desiree, Widenmaier, Robyn, Stokes, Michael, Ganz, Michael L., Jung, Hyosung, Varghese, Lijoy, Curran, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748891/
https://www.ncbi.nlm.nih.gov/pubmed/31250218
http://dx.doi.org/10.1007/s40258-019-00491-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748891/
https://www.ncbi.nlm.nih.gov/pubmed/31250218
http://dx.doi.org/10.1007/s40258-019-00491-6

Ejemplares similares